XPENG-MOTORS
9.6.2020 19:04:05 CEST | Business Wire | Press release
Xpeng Motors, a leading electric vehicle and technology company, today reveals an exclusive inside view into its self-built wholly-owned factory in Zhaoqing, Guangdong Province.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200609005686/en/
The Zhaoqing Xpeng Motors Intelligent Industrial Park, birthplace of the super-long range sports sedan Xpeng P7, was built over a period of 15 months. On May 19, 2020 the factory received the official production license from China’s Ministry of Industry and Information Technology.
Find the pictures and videos revealing the interior of the factory here: https://drive.google.com/drive/folders/1RzxP_eVWDWwVdnfaYTt01G7hn3F-ZZeS?usp=sharing
“We are deeply proud of our achievement as a young company, in building our own wholly-owned smart manufacture base at Zhaoqing,” said He Xiaopeng, Chairman and CEO of Xpeng Motors.
“Xpeng is now the only new smart EV maker in China that has both self-owned and contracted plants. We are a firm believer that manufacturing is the foundation of smart cars. Only when you build solid powertrain and vehicle hardware, can you differentiate with data operation, autonomous driving and connectivity software,” He added.
“This not only gives us optimal insight into and control over our production process, it also demonstrates our capabilities in successfully managing our supply chain and executing major projects. This is a great base for future development in intelligent vehicle design and manufacture,” He concluded.
Spanning a planned area of 3,000 acres (2 million square metres), it has five cutting-edge workshops including stamping, welding, painting, final assembly, and battery pack production.
The factory is run by a 600-member professional team. 74% of the engineers are with 5+ year working experience with 78% joined from leading OEMs.
Stamping Workshop
The stamping workshop is 100% automated. Steel plates are stamped and formed on the 6,600-ton large CNC (computer numerical control) automatic stamping production line, delivering as many as 12 pieces per minute, higher than the 10% industry average, with a precision range as narrow as 0.1 millimeter.
Equipped with an industry-leading information system, the production process is highly open and transparent, with real-time monitoring of processing parameters to ensure high quality consistency.
Welding Workshop
The Zhaoqing welding workshop is equipped with 210 ABB industrial robots, meticulously performing multiple processes including gluing, welding and aluminum plate riveting. Tier-1 and Tier-2 final assemblies reach a 100% automation rate, with the capability to manufacture steel-aluminum hybrid vehicle bodies.
The factory’s self-adaptive medium frequency welding machine achieves 30% energy saving, while the advanced visual gluing system yields gluing accuracy as fine as 0.5 millimeter.
Painting Workshop
Sophisticated styling requires exceptional painting techniques. The Zhaoqing factory’s thin film pretreatment and cathode electrophoretic technology effectively reduces wastewater discharge, while slag yield is also cut down by 94%, reducing energy consumption by approximately 25%, and achieving zero emission of heavy metal pollutants.
The painting workshop adopts world-class BASF high-throwing-power coating material, with B1B2+2K water-based varnish double-layer painting technology, significantly improving paint quality while protecting the environment too.
Assembly Workshop
Thanks to an automatic material supply and distribution system, AGV technology, automatic gluing robots and assembly technology, all components are efficiently and meticulously assembled in the Zhaoqing factory.
All the key torque joints of CBUs (Complete Built Up) are tested online through a powerful digital production system, ensuring 100% quality control of all key torque joints of the build-up.
Battery Pack Workshop
The pack workshop utilizes an AGV flexible production line, combining high-precision visual systems and robots to execute intelligent operations. The intelligent end-of-line testing system conducts comprehensive testing – including 198 offline tests and 89 battery performance tests - for every battery pack, including insulation, SOC performance and BMS function to ensure that every battery pack meets the industry-leading IP68 sealing protection requirements.
The Xpeng P7 will go through 18 vigorous quality control procedures. Each vehicle will also go through over 1,700 dynamic and static tests, and 18 simulated road condition tests for control, braking, comfort, sealing, and abnormal sound to guarantee its quality.
Zhaoqing Xpeng Motors Intelligent Industrial Park – At a Glance
- Total planned area: 3,000 acres (2 million square metres)
- Vehicle production facilities area: 1,500 acres (1 million square metres).
- Phase 1 construction: 900 acres (600,000 square metres)
- Foundation-laying: December 2017
- Construction completion: September 2019
- MIIT production license: received on 19 May 2020
- Industry 4.0 standards
- Five workshops
- 264 intelligent industrial robots
For more P7 videos and images please visit: https://drive.google.com/open?id=1mjds6n51HszTF5YhDcbaViucSwLjeiio
About XPENG Motors
Xpeng Motors is a leading Chinese electric vehicle company that designs and manufactures automobiles that are seamlessly integrated with the Internet and utilize the latest advances in artificial intelligence. The company's initial backers include its Chairman & CEO, He Xiaopeng, who’s also the co-founder of UCWeb Inc. and a former Alibaba executive. Established in 2014, Xpeng Motors has a senior management team with diverse backgrounds, including Co-founders Henry Xia and He Tao, both former senior executives at Guangzhou Auto with expertise in innovative automotive technology and R&D, and Vice Chairman & President Brian Gu, former Chairman of Asia Pacific Investment Banking at J.P. Morgan. It has received funding from strategic investors Alibaba Group and Xiaomi Corporation, as well as other prominent Chinese and international investors including IDG Capital, Morningside Venture Capital, GGV Capital and Primavera Capital. The company launched its first production model, the G3 SUV, in Dec 2018, and will launch its second production model, the P7 electric sports sedan, in April 2020 with deliveries to Chinese customers in Q2 2020. Xpeng Motors is headquartered in Guangzhou, China with offices in Beijing, Shanghai, Silicon Valley and San Diego in the U.S. and manufacture centers in Zhengzhou and Zhaoqing. For more information, please visit the official website: https://en.xiaopeng.com/
Follow us on social media for latest Xpeng news:
Facebook Twitter LinkedIn YouTube Instagram
View source version on businesswire.com: https://www.businesswire.com/news/home/20200609005686/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
First Randomized Controlled Trial Shows Promise of a Ketogenic Diet in Psychotic Disorders8.7.2026 15:00:00 CEST | Press release
Trial reports correlations between ketone levels and cognitive and psychiatric symptoms in individuals with schizophrenia-spectrum and bipolar-1 disorders Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the University of California, San Francisco (UCSF), and funded in part by the National Institute of Mental Health (NIMH), adds to growing literature on the potential benefit of a ketogenic diet for treating psychotic disorders. The study, which enrolled participants with schizophrenia-spectrum or bipolar-1 disorders, demonstrated rapid metabolic improvements with a ketogenic diet compared to diet-as-usual during an initial one-month RCT open-label phase. Furthermore, those who continued with the optional four-month single-arm ketogenic diet extension saw meaningful gains across metabolic, psychiatric, and cognitive measures. This press release features multimedia. View the full release here: https://www.businesswire.co
Teamily AI Publicly Launches Human+AI Social Platform to Make Building and Growing a Company Easy for Every Team8.7.2026 15:00:00 CEST | Press release
Teamily AI (https://Teamily.ai), together with its Agentic AI Infra platform TensorOpera AI (https://TensorOpera.ai), today announced the public launch of its Human+AI social platform, a product stack that has already served more than 5 million users around the world. Starting today in Palo Alto and rolling out simultaneously across dozens of countries, this first public launch opens the full stack to everyone with a single mission: to make building and growing a company easy for every person and every team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708584390/en/ "This is the moment we open our doors to the world," said co-founders Dr. Aiden Chaoyang He and Professor Salman Avestimehr. "We want every person and every team to be able to move from idea to product, from product to market, and from market to growth and investment, with an AI-native team by their side." At its core, Teamily AI enables humans and AI agents
Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform8.7.2026 14:30:00 CEST | Press release
Oversubscribed round follows the world-first compact upright proton treatment at Stanford Medicine — funding a single upright platform that will span imaging and treatment across multiple radiation modalities. Leo Cancer Care, the medical technology company working to reinvent how patients are imaged and treated by designing systems around the body’s natural upright position, today announced the close of an oversubscribed $65 million Series D financing. The round was led by Silicon Valley’s Yu Galaxy and welcomes new investors including Eventide Asset Management, alongside continued support from the company’s existing investors. Leading cancer institutions are already adopting the upright approach. Stanford Medicine delivered the world’s first compact upright proton therapy treatment on 4 June 2026. Dana-Farber Cancer Institute and McLaren Health Care are among the institutions bringing the upright platform into their programmes — adoption that spans world-leading academic centers and
LUMI AI Factory Selects IQM to Deploy Advanced Quantum Computer, Accelerating Hybrid HPC and AI Development8.7.2026 14:00:00 CEST | Press release
The Halocene H4 quantum computer, named LUMI-IQ, will be delivered and installed in 2027 The system will be hosted at CSC – IT Center for Science in Finland and integrated into the LUMI AI Factory The system will provide researchers, industry innovators, and developers across Europe with a unique, advanced experimental platform where quantum computing and artificial intelligence converge The LUMI AI Factory, led by CSC – IT Center for Science, has selected IQM Quantum Computers (Nasdaq: IQMX) to deliver IQM Halocene H4, an advanced quantum computer aimed at accelerating hybrid high-performance computing, artificial intelligence, and quantum computing capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708006791/en/ LUMI AI Factory selects IQM to deploy advanced quantum computer, accelerating hybrid HPC and AI development IQM Halocene H4 is the first and most advanced on-premises superconducting quantum computer o
Merck Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients With Active Skin Manifestations8.7.2026 14:00:00 CEST | Press release
Enpatoran could address a significant unmet need in lupus, specifically targeting cutaneous manifestations of the disease, which currently have no approved therapiesFDA's decision was supported by Phase 2 WILLOW study results, which demonstrated meaningful symptoms improvement, particularly among patients with active cutaneous manifestationsEnpatoran's potential to go beyond current treatment standards in lupus prompted FDA´s breakthrough designation, which is designed to expedite drug development and reviewNot intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to enpatoran for the treatment of lupus with active cutaneous manifestations. Enpatoran is an oral selective toll-like receptor (TLR) 7/8 inhibitor, designed to modulate pathways central to lupus-related inflammation. “For the 85% of lupus patients whose disease includes skin manif
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom